MedTrace Logo

Vagus Nerve Stimulation in Fibromyalgia

NCT06237595 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2024-02-01

No results posted yet for this study

Summary

Vagus nerve stimulation is thought to reduce sympathetic nerve outflow and so can improve sympathetic hyperactivity in fibromyalgia patients. We aimed in the current study, to evaluate the effect of the cervical transcutaneous vagus nerve stimulation in comparison to conventional medical treatment in Egyptian fibromyalgia patients.

Conditions

  • Fibromyalgia

Interventions

DEVICE

Vagus nerve stimulation

Electrical stimulation of the vagus nerve.

DRUG

Medical treatment

Medical treatment for fibromyalgia patients

COMBINATION_PRODUCT

Combined vagus nerve stimulation and medical treatment

Combination of the two interventions

Sponsors & Collaborators

  • Kasr El Aini Hospital

    lead OTHER

Principal Investigators

  • Hadeel A Elegily, DR · kasr Elainy Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-30
Primary Completion
2024-10-30
Completion
2025-02-28

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06237595 on ClinicalTrials.gov